Amgen Inc. (Nasdaq:AMGN) announced that the U.S. Food and Drug Administration (FDA) has approved modified language in the prescribing information for the use of erythropoiesis-stimulating agents (ESAs), including Aranesp® (darbepoetin alfa) and EPOGEN® (Epoetin alfa), in patients with chronic kidney disease (CKD). The modified language, including changes to the Boxed Warning, provides important new information for the treatment of patients with CKD who are on dialysis, as well as those not on dialysis, to inform prescribers and patients of safety risks that have been identified in clinical trials. In recognition of the different benefit-risk profiles of ESA therapy in patients on dialysis compared to patients not on dialysis, the modified labeling provides separate treatment guidance for these two CKD populations.

Amgen Inc., a biotechnology medicines company, discovers, develops, manufactures, and markets human therapeutics based on advances in cellular and molecular biology for grievous illnesses primarily in the United States, Europe, and Canada.

************************************************

People with ALS gradually become more disabled. How quickly the disease gets worse is different for everyone. Some people live with ALS for several years. But over time, ALS makes it hard to walk, speak, eat, swallow, and breathe. These problems can lead to injury, illness, and eventually death. In most cases, death will occur within 3 to 5 years after symptoms begin, although some people do live for many years, even decades.

Power3 Medical Products, Inc. (OTC.BB:PWRM) is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig’s disease).

Power3 Medical Products, Inc. applies proprietary methodologies to discover and identify protein biomarkers associated with diseases. Through these processes, Power3 Medical has developed a portfolio of products including BC-SeraPro™, a proteomic blood serum test for the early detection of breast cancer for which it has completed Phase I clinical trials, and NuroPro®, a proteomic blood serum test for the detection of neurodegenerative diseases, including Alzheimer’s, Parkinson’s, and ALS diseases, for which it is currently engaged in Phase II clinical trials. These tests are designed to analyze an individual’s proteins to detect the presence of disease, a patient’s disease progression, a patient’s response to a particular drug, and the mechanisms of disease present in the patient for optimal targeted therapy.

The NuroPro Blood Test is Power3’s medical diagnostic tool for the early detection of Neurodegenerative diseases. The analysis is designed as a tool for physicians to diagnose various degenerative diseases of the brain and nervous system. The test involves monitoring the concentration of 59 proteins in blood serum to accurately detect and distinguish between Alzheimer’s disease, ALS (Lou Gehrig’s disease), and Parkinson’s disease. Early detection of these diseases will allow physicians to intervene at an early stage to delay disease progression, potentially allowing patients to outlive their debilitating symptoms.

Please visit Power3 Medical Products, Inc website http://www.power3medical.com.

************************************************

More than 50 million Americans are uninsured: More than 7 million of them are children; more than eight out of 10 are in working families. They are our friends, neighbors and colleagues–forced to gamble every day that they won’t get sick or injured.

Living without health insurance is a risk no one should have to take.

The healthcare industry remains in a state of turmoil and crisis. Each year, the cost of insurance skyrockets. The uninsured rate is higher among people with lower incomes.

The need for affordable healthcare alternatives has never been greater.

National Health Partners, Inc., (NHPR.OB), a leading provider of discount healthcare membership programs, announced the recent signing of two new significant marketing agreements. These two clients provide very different opportunities and continue to expand the reach of CARExpress into new marketplaces.

By launching their own unique internet marketing program, the first group should be able to provide a widespread push into the on-line market to produce an excellent volume of new CARExpress sales into the pipeline. In addition, the second group offers a reach into the wholesale marketplace where CARExpress will be wrapped into other programs to enhance the value of the overall package to the consumer. They would consider this non-traditional business and a great opportunity to expand their reach as well as recognition of the CARExpress program nationwide.

The company plans to announce the rollout of these new marketing campaigns as well as several others over the next few weeks.

More about NHPR at www.nationalhealthpartners.com

************************************************

Charter Communications Inc. (Nasdaq:CHTR) announced that Michael Lovett, President and Chief Executive Officer, will participate in the Guggenheim Media Symposium Conference this morning in New York, NY. Mr. Lovett is participating in a broadband distribution panel discussion that is expected to begin at approximately 11:00 am ET. A live audio webcast will be available online on Charter’s website at www.charter.com. The webcast can be accessed by selecting “Investor & News Center” from the lower menu on the home page, then “Financial Information”. To listen to the live webcast, please go to the website at least 15 to 20 minutes prior to the start to register, as well as download and install any necessary software. A replay will be available shortly after the conclusion of the presentation through midnight ET on July 6, 2011.

Charter Communications, Inc. provides cable services to residential and commercial customers in the United States.

************************************************

Tibco Software, Inc. (Nasdaq:TIBX) announced that it hosted a live launch event on Tuesday, June 28 to unveil tibbr® 3.0, the third generation of its enterprise social computing platform that is transforming the way companies collaborate. tibbr builds on TIBCO’s decades of experience in linking enterprise software systems, and connects not just people, but also systems, processes, applications, and subjects and makes them part of the conversation.

TIBCO Software Inc. provides middleware and infrastructure software worldwide. It offers its products in the areas of service-oriented architecture (SOA), business optimization, and business process management (BPM).

*************************************************************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. DrStockPick.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold DrStockPick.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://drstockpick.com/disclaimer). Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.

Crown Equity Holdings Inc. (CRWE.OB) has received 1,000,000 shares 144 restricted stocks for IT department services and 2,000,000 shares (free trade) for 12 months of video production from Power 3 Medical Products Inc. (PWRM.OB).

Crown Equity Holdings Inc. (CRWE.OB) has received 3,000,000 shares of (144) restricted common stock from the company and 3,000,000 shares of free trading shares from a third party (PIERRE BESUCHET) for six months of advertisement services for National Health Partners Inc. (NHPR.OB).

Hansen Medical, Inc. (NASDAQ:HNSN), a global leader in flexible robotics and the developer of robotic technology for accurate 3D control of catheter movement, announced that veteran financial executive Peter J. Mariani has been named Chief Financial Officer, effective June 20. He will report directly to President and Chief Executive Officer Bruce Barclay.

Hansen Medical, Inc. develops, manufactures, and markets medical robotics designed for accurate positioning, manipulation, and stable control of catheters and catheter-based technologies.

****************************************************

An Alzheimer’s disease diagnosis is based on the results of a variety of diagnostic tests in conjunction with the observations of an experienced clinician. There is no single diagnostic test for Alzheimer’s disease. Rather, an AD diagnosis is based on the results of a variety tests that include neurological examinations, mental status examinations, neuropsychological and psychiatric evaluations, physical examination including laboratory tests, the patient’s past medical history and medications that the patient is currently taking.

Power3 Medical Products, Inc. (OTC.BB:PWRM) is a leading edge biotechnology company engaged in the early detection, monitoring, and targeting of diseases through the analysis of proteins. This dynamic team utilizes proteomics in the discovery of protein biomarkers, drug pathways, and mechanisms of disease.

Power3 Medical is a breakthrough proteomics company specializing in the identification of disease footprints in the areas of chemotherapeutic drug resistance and the early detection of breast cancer and neurological diseases. The research platform is centered on the study of proteomics, the science of protein interactions within living cells. With a combined 50+ years of proteomic experience, the Company has identified 334 protein biomarkers with the following potential medical applications:

Breast Cancer Chemotherapeutic Drug Resistance
Alzheimer’s Disease Leukemia
ALS (Lou Gehrig’s Disease) Gastrointestinal Disease
Parkinson’s Disease Metabolic Syndrome

These discovered and patent-pending biomarkers solve critical challenges facing pharmaceutical and diagnostic companies and are currently being used to design tests to diagnose diseases and discover targets for new drugs to treat the diseases.

Power3 Medical Products, Inc uses the NuroPro Blood Test as a diagnostic tool for the early detection of Neurodegenerative diseases. The analysis is designed as a tool for physicians to diagnose various degenerative diseases of the brain and nervous system. The test involves monitoring the concentration of 59 proteins in blood serum to accurately detect and distinguish between Alzheimer’s disease, ALS (Lou Gehrig’s disease), and Parkinson’s disease. Early detection of these diseases would allow physicians to intervene at an early stage to delay disease progression, potentially allowing patients to outlive their debilitating symptoms.

For more information, please visit: http://www.power3medical.com

****************************************************

Online targeted marketing offers almost immediate access to potential customers. Some of its benefits include easily spreading the word about a new company or product, reaching a large number of targeted consumers, and cost-effectiveness. Likewise, online marketing can drive a lot of traffic to web sites, convert users almost instantly, and make it easy to get real-time statistics.

The ability to quickly create interest in a company or product is one of the biggest benefits of online targeted marketing. The use of social networks, e-mail marketing campaigns, and online advertising makes it easy for the information to “go viral.” An interesting or funny advertisement can be sent electronically from one Internet user to the next, creating a lot of interest and exposure.

Crown Equity Holdings Inc. (OTC:CRWE) recently announced that it has extended its CRWENEWSWIRE global platform web presence and is now publishing online news and information to the following countries: Argentina, Australia, Brazil, Canada, China, France, Germany, India, Ireland, Italy, Japan, Malaysia, Mexico, New Zealand, Russia, Singapore, South Africa, South Korea, Spain, Taiwan, United Arab Emirates and the United Kingdom, using their specific country code domain and native language.

Crown Equity Holdings Inc., together with its digital network, currently provides electronic media services specializing in online publishing, which brings together targeted audiences and advertisers. Crown Equity Holdings Inc. offers internet media-driven advertising services, which covers and connects a range of marketing specialties, as well as search engine optimization for clients interested in online media awareness.

CRWE’s digital network is designed, on behalf of its clients, to bring together targeted high-income audiences and advertisers on its financial websites that include, among others, DrStockPick.com, PennyOmega.com, BestOtc.com, CRWEFinance.com, CRWESelect.com, CRWEPicks.com and StockHotTips.com.

The company’s wholly owned subsidiary, Crown Tele Services Inc., has completed installing servers for its business, which is currently in the process of preparing to provide and offer its “VoIP” communication services to small, large and enterprise businesses.

For more information, please visit: http://www.crownequityholdings.com

****************************************************

Veeco Instruments Inc. (Nasdaq:VECO) announced that Taiwan-based Formosa Epitaxy (FOREPI) and its Chinese affiliate, Jiangsu Canyang Corporation, have placed a multi-unit order for Veeco’s recently released TurboDisc® MaxBright™ Multi-Reactor MOCVD System for production of high-brightness light-emitting diodes (HB LEDs).

Veeco Instruments Inc. designs, manufactures, and markets equipment to make high brightness light emitting diodes (HB LEDs), solar panels, hard-disk drives, and other devices.

****************************************************

Acme Packet (NASDAQ:APKT) announced that the leading UK-based Communications-as-a-Service (CaaS) and wholesale service provider HIPCOM has deployed Acme Packet’s Net-Net® 4500 session border controllers (SBCs) to support the expansion of its wholesale business access services to include unified communications (UC) based on Microsoft Lync 2010. The SBCs are utilized for SIP trunking and core functions that secure HIPCOM’s service infrastructure, normalize SIP signaling and intelligently segment its network.

Acme Packet, Inc. provides session border controllers (SBCs). The SBCs enable service providers, enterprises, and contact centers to deliver interactive communications; voice, video, and multimedia sessions; and data services across Internet protocol (IP) network borders worldwide.

*************************************************************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. DrStockPick.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold DrStockPick.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://drstockpick.com/disclaimer). Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (CRWE.OB) has received 1,000,000 shares 144 restricted stocks for IT department services and 2,000,000 shares (free trade) for 12 months of video production from Power 3 Medical Products Inc. (PWRM.OB).

Sonic Corp. (NASDAQ:SONC) announced that it plans to report third quarter results at the market close on June 22, 2011. The company will provide an online web simulcast of its earnings release conference call that afternoon beginning at 5:00 p.m. ET. During that call, management will comment on Sonic’s financial and operational results for the third quarter of fiscal 2011. An online replay of the conference call will be available approximately two hours after the conclusion of the live broadcast and will continue through July 22, 2011. A link to these events will be available at the investor section of the company’s website, www.sonicdrivein.com.

Sonic Corp. operates and franchises a chain of quick-service drive-in restaurants in the United States. As of August 31, 2010, the company operated approximately 3,572 Sonic Drive-Ins, including 455 company-owned Drive-Ins and 3,117 franchised Drive-Ins. It also leases signs and real estate.

*********************************************************

Biomass includes all of the earth’s living matter, plants and animals, and the remains of this living matter. Plant biomass is a renewable energy source that is produced through photosynthesis when plants capture carbon dioxide from the air and combine it with water to form carbohydrates and oxygen under the influence of sunlight. The chemical energy in plants gets passed on to animals and people that eat the plants. Biomass does not include plant or animal matter that has been converted by geologic processes to create fossil fuels such as oil or coal.

Cleantech Transit Inc. (”Cleantech”) (OTC.BB:CLNO) original aim was to develop opportunities utilizing advances in technology and manufacturing processes in order to develop significant market share in the growing clean energy public transportation sector.

The Company has expanded its focus to invest directly in specific green projects that can maximize shareholder value. Recognizing the many economic and operational advances of converting wood waste into renewable sources of energy, Cleantech has selected to invest in Phoenix Energy (www.phoenixenergy.net). This project can generate shareholder returns as well benefit the Company’s manufacturing clients worldwide.

Cleantech Transit Inc. is pleased to provide further details on finalizing the 500 KW project. Cleantech expects to finalize its initial interest in the project around July 15th and is in talks to further increase its interest in the 500 KW project in Merced County. In addition, the Company hopes to negotiate definitive terms for the previously announced larger projects. In particular Cleantech is interested in the larger 1 MW biomass gasification facilities and will provide additional details as the Company has confirmed terms on the larger projects.

“We are pleased to be making progress towards building a portfolio of green friendly assets and hopes to build off the success the 500 KW Merced Project has achieved thus far,” said Mr. Kenneth Bosket, Cleantech’s President and CEO.

To discover more about CLNO, Please visit: http://www.cleantechtransitinc.com/

*********************************************************

Power3 Medical Products, Inc. (OTC.BB:PWRM) is a leading edge biotechnology company engaged in the early detection, monitoring, and targeting of diseases through the analysis of proteins. This dynamic team utilizes proteomics in the discovery of protein biomarkers, drug pathways, and mechanisms of disease.

Power3 Medical Products, Inc. strives to become the premier biotechnology company specializing in the commercialization of proteomics IP for the diagnosis and treatment of disease by using cutting edge technologies, world class quality procedures and superior research methodologies. The Company will be guided in all of its dealings with its customers, partners, shareholders, associates and investors by the philosophy of best practices.

Power3 Medical Products, Inc uses the NuroPro Blood Test as a diagnostic tool for the early detection of Neurodegenerative diseases. The analysis is designed as a tool for physicians to diagnose various degenerative diseases of the brain and nervous system. The test involves monitoring the concentration of 59 proteins in blood serum to accurately detect and distinguish between Alzheimer’s disease, ALS (Lou Gehrig’s disease), and Parkinson’s disease. Early detection of these diseases would allow physicians to intervene at an early stage to delay disease progression, potentially allowing patients to outlive their debilitating symptoms.

Parkinson’s is caused by a problem in the brain with nerve cells. The nerve cells stop making the neurotransmitter called dopamine which affects muscles and motor function. There is no cure but there are treatments that help with the symptoms of Parkinson’s disease. Speculations on the cause of the illness include abnormal genes that are affected by the aging process and environmental influences. Environmental influences may include toxic chemicals, air and water pollution, detergents, dyes, perfumes, and preservatives found in processed foods. There has been some speculation that aluminum included in antiperspirants and deodorants can lead to Parkinson’s but there is not conclusive proof that this is true.

For more information, please visit: http://www.power3medical.com

*********************************************************

Verisk Analytics, Inc. (Nasdaq:VRSK) announced it has signed an agreement to acquire Health Risk Partners, LLC (HRP), a leading provider of solutions to optimize revenue, ensure compliance, and improve quality of care for Medicare Advantage and Medicaid health plans. The acquisition is subject to the completion of customary closing conditions. Based in Richmond, Virginia, HRP has a customer base representing more than 5.5 million Medicare Advantage, Medicare Part D, and Medicaid lives.

Verisk Analytics, Inc. provides proprietary data, analytics methods, and embedded decision support solutions to property and casualty (P&C) insurance, mortgage, and healthcare industries primarily in the United States.

*********************************************************

Dollar General (NYSE:DG) recently broke ground on its 10th distribution center in Bessemer, Ala. The $100 million facility, located on more than 100 acres at 4101 Lakeshore Parkway, should eventually employ 650 people and will be the largest such facility in Jefferson County.

Dollar General Corporation has been delivering value to shoppers for more than 70 years. Dollar General helps shoppers Save time. Save money. Every day!® by offering products that are frequently used and replenished, such as food, snacks, health and beauty aids, cleaning supplies, basic apparel, house wares and seasonal items at low everyday prices in convenient neighborhood locations.

*************************************************************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. DrStockPick.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold DrStockPick.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://drstockpick.com/disclaimer). Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.

Crown Equity Holdings Inc. (CRWE.OB) anticipates receiving 5,000,000 shares of 144 restricted stocks from the company for 12 months of media advertisement and IR services for Cleantech Transit, Inc. (CLNO.OB).

Crown Equity Holdings Inc. (CRWE.OB) has received 1,000,000 shares 144 restricted stocks for IT department services and 2,000,000 shares (free trade) for 12 months of video production from Power 3 Medical Products Inc. (PWRM.OB).

Roper Industries, Inc. (NYSE:ROP) announced that it has completed the previously announced acquisition of Northern Digital, Inc., a leading provider of 3-D measurement technology for medical applications. Headquartered in Waterloo, Ontario, Canada, Northern Digital provides optical and electromagnetic measurement systems for medical and industrial applications. NDI’s technology is used in the growing fields of computer-assisted surgery, computer-assisted therapy and image-guided radiation treatment.

Roper Industries, Inc. designs, manufactures, and distributes medical and scientific imaging products and software, energy systems and controls, and industrial technology products and radio frequency (RF) products and services.

****************************************************

People who have Parkinson’s disease experience tremors or shaking as a result of the damage to their nerve cells. Tremors caused by Parkinson’s get worse when the person is at rest and better when the person moves. The tremor may affect one side of the body more than the other, and can affect the lower jaw, arms and legs. Handwriting may also look “shaky” and smaller than usual. Other symptoms of Parkinson’s disease include nightmares, depression, extra saliva, difficulty walking or buttoning clothes, or cutting food.

Power3 Medical Products, Inc. (OTC.BB:PWRM) applies proprietary methodologies to discover and identify protein biomarkers associated with diseases. Through these processes, Power3 Medical has developed a portfolio of products including BC-SeraPro™, a proteomic blood serum test for the early detection of breast cancer for which it has completed Phase I clinical trials, and NuroPro®, a proteomic blood serum test for the detection of neurodegenerative diseases, including Alzheimer’s, Parkinson’s, and ALS diseases, for which it is currently engaged in Phase II clinical trials. These tests are designed to analyze an individual’s proteins to detect the presence of disease, a patient’s disease progression, a patient’s response to a particular drug, and the mechanisms of disease present in the patient for optimal targeted therapy.

The NuroPro Blood Test is Power3’s medical diagnostic tool for the early detection of Neurodegenerative diseases. The analysis is designed as a tool for physicians to diagnose various degenerative diseases of the brain and nervous system. The test involves monitoring the concentration of 59 proteins in blood serum to accurately detect and distinguish between Alzheimer’s disease, ALS (Lou Gehrig’s disease), and Parkinson’s disease. Early detection of these diseases will allow physicians to intervene at an early stage to delay disease progression, potentially allowing patients to outlive their debilitating symptoms.

Power3 Medical Products, Inc. is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig’s disease).

Please visit Power3 Medical Products, Inc website http://www.power3medical.com.

****************************************************

Biomass is a clean renewable energy resource derived from the waste of various human and natural activities. It excludes organic material which has been transformed by geological processes into substances such as coal or petroleum. The energy of biomass is extracted from distinct sources:

* Wood
* Waste
* Alcohol fuels
* Crops
* Landfill gases

Cleantech Transit Inc. (”Cleantech”) (OTC.BB:CLNO) was founded to capitalize on technology advances and manufacturing opportunities in the growing clean energy public transportation sector. The Company has expanded its focus to invest directly in specific green projects. Recognizing the many economic and operational advances of converting wood waste into renewable sources of energy, Cleantech has selected to invest in Phoenix Energy (www.phoenixenergy.net). This project can generate shareholder returns as well benefit the Company’s manufacturing clients worldwide.

Cleantech Transit Inc. is pleased to provide additional details after achieving success on the 500 KW facilities and successfully moving past the interconnection testing stage.

Coming on the recent success at the 500KW facility in Merced, California this poises Phoenix Energy to become a leading developer of renewable biomass distributed generation plants that utilize local resources for local energy.

Currently there are two additional projects being pre-certified by Phoenix Energy in California. The projects are each projected to be 1 MW biomass gasification facilities that will provide both electricity and process heat energy. Each facility will provide enough electricity to power approximately 800 homes as well as process heat to be used in drying agricultural products. The projects are expected to complete by the end of 2012.

Phoenix Energy is an owner/operator of small-scale distributed energy plants that produce electricity, heat and biochar in partnership with businesses in the Ag, forestry and urban biomass sectors. The Company promotes a model of sustainability by bringing small, sustainable power plants to the site of energy demand and biomass residues.

Cleantech will be providing details on the expecting closing date of its initial investment into Phoenix Energy in the coming weeks.

Cleantech Transit Inc. is in the business of producing and conserving power. It produces and sells clean electricity globally, with a focus on sustainable energies using renewable resources such as Geothermal, Solar and Wind.

To discover more about CLNO, Please visit: http://www.cleantechtransitinc.com/

****************************************************

Canadian Imperial Bank of Commerce (NYSE:CM) announced the top 10 dancers who will take part in the live finale of the CIBC IIFA Bollywood Moves Dance Competition for a once-in-a-lifetime chance to perform on stage at the 2011 International Indian Film Academy Awards.

Canadian Imperial Bank of Commerce provides various financial products, services, and advice to individual, small business, commercial, corporate, and institutional clients in Canada and internationally.

****************************************************

Nike Inc. (NYSE:NKE) announced the launch of “The Chosen,” a new global ‘Just Do It’ campaign featuring a pantheon of action sports stars. The centerpiece of the campaign is a film featuring skate legend Paul Rodriguez (P-Rod), Olympic snowboarder Danny Kass, surf prodigies Julian Wilson and Laura Enever. The film was shot all over the world at night and features lighting and pyrotechnics reminiscent of a live rock concert.

NIKE, Inc. designs, develops, and markets footwear, apparel, equipment, and accessory products for men, women, and children worldwide.

*************************************************************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. DrStockPick.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold DrStockPick.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://drstockpick.com/disclaimer). Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.

Crown Equity Holdings Inc. (CRWE.OB) has received 1,000,000 shares 144 restricted stocks for IT department services and 2,000,000 shares (free trade) for 12 months of video production from Power 3 Medical Products Inc. (PWRM.OB).

Crown Equity Holdings Inc. (CRWE.OB) anticipates receiving 5,000,000 shares of 144 restricted stocks from the company for 12 months of media advertisement and IR services for Cleantech Transit, Inc. (CLNO.OB).